P

Inventor

GETMAN DANIEL

US32 patents
⚠️ This page may combine multiple inventors who share the name “GETMAN DANIEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SEARLE & CO

26 patents
US5843946ADec 1, 1998

α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

SEARLE & CO78 citations97
US6534493B1Mar 18, 2003

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

SEARLE & CO26 citations96
US6472407B1Oct 29, 2002

α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

SEARLE & CO21 citations96
US6335460B1Jan 1, 2002

α-and β-amino acid hydroxyethlamino sulfonamides useful as retroviral protease inhibitors

SEARLE & CO28 citations96
US6172082B1Jan 9, 2001

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

SEARLE & CO24 citations96
US5965588AOct 12, 1999

Sulfonylalkanoylamino hydroxyethylamimo sulfonamides useful as retroviral protease inhibitors

SEARLE & CO66 citations96
US5786483AJul 28, 1998

α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

SEARLE & CO26 citations96
US5760064AJun 2, 1998

Sulfonylalkanoylamino hydroxyethylamino sulfanamides useful as retroviral protease inhibitors

SEARLE & CO40 citations96
US5744481AApr 28, 1998

β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

SEARLE & CO51 citations96
US5639769AJun 17, 1997

Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

SEARLE & CO36 citations96
US5521219AMay 28, 1996

Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

SEARLE & CO54 citations96
US5508294AApr 16, 1996

Sulfonylalkanoylamino hydroxyethlamino sulfonamides useful as retroviral protease inhibitors

SEARLE & CO41 citations96
US6313345B1Nov 6, 2001

Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

SEARLE & CO19 citations93
US6022994AFeb 8, 2000

Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

SEARLE & CO23 citations93
US5830897ANov 3, 1998

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

SEARLE & CO47 citations93
US5760076AJun 2, 1998

Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

SEARLE & CO32 citations93
US5510388AApr 23, 1996

Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

SEARLE & CO27 citations93
US5463104AOct 31, 1995

Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

SEARLE & CO23 citations93
US6875790B2Apr 5, 2005

Cyclic sulfone containing retroviral protease inhibitors

SEARLE & CO16 citations92
US5849784ADec 15, 1998

Cyclic sulfone containing retroviral protease inhibitors

SEARLE & CO13 citations82
US6265583B1Jul 24, 2001

Cyclic sulfone containing retroviral protease inhibitors

SEARLE & CO6 citations74
US6147117ANov 14, 2000

Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

SEARLE & CO3 citations74
US6743929B1Jun 1, 2004

Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

SEARLE & CO3 citations63
US6727282B2Apr 27, 2004

Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

SEARLE & CO2 citations63
US6469207B2Oct 22, 2002

Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

SEARLE & CO3 citations63
US7038084B2May 2, 2006

Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

SEARLE & CO0 citations52

MONSANTO CO

4 patents

TIBOTEC PHARM LTD

1 patent

PHARMACIA & UPJOHN CO LLC

1 patent